180 related articles for article (PubMed ID: 21883266)
1. Long-term follow-up among Danish transfusion recipients identified in the national hepatitis C lookback.
Just SA; Grau K; Georgsen J; Weis N; Cowan S; Groenbaek K; Krarup H; Christensen PB;
Transfusion; 2012 Mar; 52(3):582-8. PubMed ID: 21883266
[TBL] [Abstract][Full Text] [Related]
2. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.
Seeff LB; Hollinger FB; Alter HJ; Wright EC; Cain CM; Buskell ZJ; Ishak KG; Iber FL; Toro D; Samanta A; Koretz RL; Perrillo RP; Goodman ZD; Knodell RG; Gitnick G; Morgan TR; Schiff ER; Lasky S; Stevens C; Vlahcevic RZ; Weinshel E; Tanwandee T; Lin HJ; Barbosa L
Hepatology; 2001 Feb; 33(2):455-63. PubMed ID: 11172349
[TBL] [Abstract][Full Text] [Related]
3. All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study.
Kielland KB; Skaug K; Amundsen EJ; Dalgard O
J Hepatol; 2013 Jan; 58(1):31-7. PubMed ID: 22960427
[TBL] [Abstract][Full Text] [Related]
4. Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study.
Omland LH; Krarup H; Jepsen P; Georgsen J; Harritshøj LH; Riisom K; Jacobsen SE; Schouenborg P; Christensen PB; Sørensen HT; Obel N;
J Hepatol; 2010 Jul; 53(1):36-42. PubMed ID: 20400197
[TBL] [Abstract][Full Text] [Related]
5. Survival of a national cohort of hepatitis C virus infected patients, 16 years after exposure.
Harris HE; Ramsay ME; Andrews NJ;
Epidemiol Infect; 2006 Jun; 134(3):472-7. PubMed ID: 16255834
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C and hepatitis B-related mortality in Spain.
García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
[TBL] [Abstract][Full Text] [Related]
7. Survival after blood transfusion.
Kamper-Jørgensen M; Ahlgren M; Rostgaard K; Melbye M; Edgren G; Nyrén O; Reilly M; Norda R; Titlestad K; Tynell E; Hjalgrim H
Transfusion; 2008 Dec; 48(12):2577-84. PubMed ID: 18673342
[TBL] [Abstract][Full Text] [Related]
8. Late liver-related mortality from complications of transfusion-acquired hepatitis C.
Kamitsukasa H; Harada H; Tanaka H; Yagura M; Tokita H; Ohbayashi A
Hepatology; 2005 Apr; 41(4):819-25. PubMed ID: 15793849
[TBL] [Abstract][Full Text] [Related]
9. Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study.
Bedogni G; Miglioli L; Masutti F; Ferri S; Castiglione A; Lenzi M; Crocè LS; Granito A; Tiribelli C; Bellentani S
Am J Gastroenterol; 2008 Sep; 103(9):2248-53. PubMed ID: 18637095
[TBL] [Abstract][Full Text] [Related]
10. Cancer incidence in blood transfusion recipients.
Hjalgrim H; Edgren G; Rostgaard K; Reilly M; Tran TN; Titlestad KE; Shanwell A; Jersild C; Adami J; Wikman A; Gridley G; Wideroff L; Nyrén O; Melbye M
J Natl Cancer Inst; 2007 Dec; 99(24):1864-74. PubMed ID: 18073377
[TBL] [Abstract][Full Text] [Related]
11. Natural history of hepatitis C.
Seeff LB
Hepatology; 1997 Sep; 26(3 Suppl 1):21S-28S. PubMed ID: 9305659
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
Loinaz C; Lumbreras C; Moreno E; Colina F; Fuertes A; Gómez R; Jiménez C; González-Pinto I; García I; Rojas J; Bellorín C
Hepatogastroenterology; 2001; 48(41):1435-42. PubMed ID: 11677981
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth.
Casiraghi MA; De Paschale M; Romanò L; Biffi R; Assi A; Binelli G; Zanetti AR
Hepatology; 2004 Jan; 39(1):90-6. PubMed ID: 14752827
[TBL] [Abstract][Full Text] [Related]
14. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C.
Buti M; San Miguel R; Brosa M; Cabasés JM; Medina M; Angel Casado M; Fosbrook L; Esteban R
J Hepatol; 2005 May; 42(5):639-45. PubMed ID: 15826711
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.
Hui JM; Kench JG; Chitturi S; Sud A; Farrell GC; Byth K; Hall P; Khan M; George J
Hepatology; 2003 Aug; 38(2):420-7. PubMed ID: 12883486
[TBL] [Abstract][Full Text] [Related]
16. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
[TBL] [Abstract][Full Text] [Related]
17. Outcomes after lung transplantation in patients with chronic hepatitis C virus infection.
Sahi H; Zein NN; Mehta AC; Blazey HC; Meyer KH; Budev M
J Heart Lung Transplant; 2007 May; 26(5):466-71. PubMed ID: 17449415
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of hepatitis C as a function of mode of transmission.
Gordon SC; Bayati N; Silverman AL
Hepatology; 1998 Aug; 28(2):562-7. PubMed ID: 9696025
[TBL] [Abstract][Full Text] [Related]
19. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of hepatitis C virus-infected Canadian post-transfusion compensation claimant cohort.
Thein HH; Yi Q; Heathcote EJ; Krahn MD
J Viral Hepat; 2009 Nov; 16(11):802-13. PubMed ID: 19413692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
